Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 185 Neoplasms 181 Carcinoma, Non-Small-Cell Lung 153 Prostatic Neoplasms 120 Colorectal Neoplasms 111 Lung Neoplasms 97 Ovarian Neoplasms 83 Neoplasm Metastasis 82 Multiple Myeloma 76 Pancreatic Neoplasms 75 Leukemia, Myeloid, Acute 65 Endometrial Neoplasms 52 Stomach Neoplasms 48 Squamous Cell Carcinoma of Head and Neck 47 Melanoma 47 Recurrence 46 Lymphoma 45 Hematologic Neoplasms 44 Glioblastoma 44 Carcinoma, Renal Cell 44 Brain Neoplasms 44 Carcinoma, Hepatocellular 42 Urinary Bladder Neoplasms 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Lymphoma, Non-Hodgkin 39 Leukemia, Lymphocytic, Chronic, B-Cell 38 Triple Negative Breast Neoplasms 35 Glioma 35 Small Cell Lung Carcinoma 34 Sarcoma 34

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hormone Receptor Positive Breast Cancer × 30 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡